Altius Biochem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.90 M
as on 16-11-2024
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -95.11%
(FY 2023)
- Profit -1066.23%
(FY 2023)
- Ebitda 240.98%
(FY 2023)
- Net Worth -52.44%
(FY 2023)
- Total Assets -89.65%
(FY 2023)
About Altius Biochem
The Corporate was formerly known as Provence Wellness Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Adarsh Basotia, Hemangini Dathia, and Swapnil Dathia serve as directors at the Company.
- CIN/LLPIN
U24231GJ2021PTC122626
- Company No.
122626
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Altius Biochem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemangini Dathia  | Managing Director | 15-May-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Adarsh Basotia | Director | 15-May-2021 | Current |
| Swapnil Dathia | Director | 15-May-2021 | Current |
Financial Performance of Altius Biochem.
Altius Biochem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 95.11% decrease. The company also saw a substantial fall in profitability, with a 1066.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Altius Biochem?
Unlock access to Altius Biochem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Neochem Technologies Private LimitedActive 7 years 7 monthsHemangini Dathia and Swapnil Dathia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Altius Biochem?
Altius Biochem has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Altius Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Altius Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
